In an adult with recent freshwater or soil exposure presenting with acute fever, severe headache, calf myalgias, conjunctival suffusion, and possible jaundice or renal dysfunction, what is the recommended initial antimicrobial therapy and supportive management for suspected leptospirosis?

Leptospirosis: Initial Management

Start empiric antibiotic therapy immediately upon clinical suspicion without waiting for laboratory confirmation, using penicillin or tetracycline antibiotics during the bacteremic phase, while preparing for potential intensive supportive care including renal replacement therapy and respiratory support for severe cases. 1

Clinical Recognition

The diagnosis should be suspected based on:

• Exposure history: Recent freshwater contact, flooding, or animal urine exposure (particularly rats, dogs, cattle) through recreational activities or occupational exposure 1
• Classic triad: Fever, severe calf myalgias, and conjunctival suffusion 1
• Biphasic course: Initial bacteremic phase with flu-like symptoms (4-7 days), followed 1-3 days later by immune phase with hepatorenal syndrome and hemorrhage 1
• Incubation period: 7-12 days (range 2-30 days) 1

Antimicrobial Therapy

Initiate antibiotics immediately upon suspicion given the non-specific nature of initial investigations. 1

Antibiotic Selection

• Penicillin or tetracycline antibiotics are recommended for the bacteremic phase 1
• Ceftriaxone 2g daily has been successfully used in severe cases 2
• Doxycycline is an alternative tetracycline option 3

Important Caveats

• While a systematic review showed no benefit for antibiotics in established leptospirosis based on three trials, most infectious disease specialists continue to recommend antibiotics, acknowledging that severe disease is probably immunologically mediated 1
• Early mild disease is generally self-limiting, but treatment should still be initiated given the unpredictable progression 1
• Jarisch-Herxheimer reaction may occur after antibiotic initiation, presenting with chills, fever, and hypotension requiring supportive care 2

Diagnostic Workup (Concurrent with Treatment)

Initial Laboratory Tests

• Urinalysis: Proteinuria and hematuria 1
• Complete blood count: Polymorphonuclear leukocytosis, thrombocytopenia, anemia if hemorrhage present 1
• Coagulation studies: Often normal despite bleeding (due to capillary fragility) 1
• Renal function: Elevated creatinine and BUN 1
• Liver function: High bilirubin with mild transaminase elevation 1

Confirmatory Testing

• Blood cultures: Obtain within first 5 days before antibiotics, keep at room temperature 1
• Serology: IgM ELISA and microscopic agglutination test (MAT)
  • IgM titer >1:320 is suggestive 1
  • Titer 1:80 to 1:160 consistent with early infection but may represent cross-reactions 1
  • Earliest positives appear 6-10 days after symptom onset 1
  • Convalescent serology >10 days after onset confirms diagnosis 1
• PCR testing: Urine PCR can provide rapid confirmation 2
• Note: Urine is NOT suitable for isolation of leptospira 1

Supportive Management by Severity

Severe Disease (Weil's Disease)

Patients with jaundice, renal dysfunction, or hemorrhage require aggressive supportive care:

Renal Support

• Nonoliguric (high output) renal failure: Aggressive fluid and electrolyte replacement 4
• Oliguric renal failure: Prompt initiation of dialysis is life-saving 4
• Monitor for hyponatremia and hypokalemia 2

Pulmonary Management

• Severe pulmonary hemorrhage syndrome has >50% mortality rate 4
• Prepare for respiratory support and mechanical ventilation 2
• Monitor chest X-ray for interstitial infiltrates and hemorrhage 2

Hemorrhagic Complications

• Common despite normal coagulation studies (due to capillary fragility) 1, 4
• Monitor for skin ecchymoses and internal bleeding 5
• Supportive transfusion therapy as needed 4

Hepatic Dysfunction

• Elevated bilirubin results from hepatocellular damage and disruption of intercellular junctions 4
• Liver support may be required 1

Mild to Moderate Disease

• Rehydration and electrolyte management 5
• Close monitoring for progression to severe disease 1
• Most cases are self-limiting over several weeks if mild 1

Prognostic Factors

• Age >60 years: Increased mortality risk 4
• High bacteremia levels: Associated with poor outcomes 4
• Cytokine storm: High IL-6, TNF-alpha, and IL-10 levels indicate severe disease 4
• Overall mortality: Approximately 5% in hospitalized patients, but 1-4% in treated cases 3

Critical Practice Points

• Do not delay treatment waiting for serological confirmation—the non-specific initial presentation necessitates empiric therapy 1
• Patients with jaundice can deteriorate rapidly despite antibiotic therapy 1
• Severe disease is likely immunologically mediated, explaining limited antibiotic efficacy in advanced cases 1
• Maintain high clinical suspicion in patients with appropriate exposure history and classic findings, even in urban settings 2